funding round
The mental health startup seeks to scale its teams and commercial expansion plans across Asia with the funding.
The health startup provides telemedicine services for insurance companies, corporations and government entities.
The conpany uses its own spectroscopic technology to detect, analyse, and quantify molecular information.
Funds from this investing round will be used for the expansion of its solutions and services.
The surgery robotics developer will use the funds to reach fast-growing cities in China and develop solutions to treat major diseases.
The AI-integrated software can be used for early detection of COVID-19 and other diseases through imaging biomarkers in Europe.